ADIL - ADIAL PHARMACEUTICALS, INC.
2.29
-0.180 -7.860%
Share volume: 1,647,221
Last Updated: 03-03-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.15%
PREVIOUS CLOSE
CHG
CHG%
$2.47
-0.18
-0.07%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 05-14-2024 | 08-13-2024 | 11-13-2024 | 03-04-2025 | 05-14-2025 | 08-13-2025 | 11-13-2025 | |
| Total revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| nan% | nan% | nan% | nan% | nan% | ||||
| Operating expenses | 1.845 M | 2.287 M | 2.211 M | 1.941 M | 2.267 M | 1.883 M | 1.764 M | |
| Selling general and admin | 1.391 M | 1.275 M | 1.180 M | 1.210 M | 1.520 M | 1.150 M | 1.243 M | |
| Research and development | 454.278 K | 1.013 M | 1.032 M | 730.793 K | 746.891 K | 732.315 K | 521.069 K | |
| Total expenses | 1.845 M | 2.287 M | 2.211 M | 1.941 M | 2.267 M | 1.883 M | 1.764 M | |
| 23.97% | -3.31% | -12.24% | 16.83% | -16.96% | -6.30% | |||
| Operating income | -1.845 M | -2.287 M | -2.211 M | -1.941 M | -2.267 M | -1.883 M | -1.764 M | |
| Ebit | -6.309 M | -2.287 M | -2.211 M | -2.016 M | -2.101 M | -1.884 M | -1.765 M | |
| Pretax income | -6.477 M | -2.458 M | -2.192 M | -2.071 M | -2.229 M | -1.959 M | -1.794 M | |
| -62.04% | -10.84% | -5.52% | 7.63% | -12.13% | -8.42% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -6.477 M | -2.458 M | -2.192 M | -2.071 M | -2.229 M | -1.959 M | -1.794 M | |
| 62.04% | 10.84% | 5.52% | -7.63% | 12.13% | 8.42% |